Avenue Therapeutics ATXI
OTC ATXI
$0.40 -0.03 (-6.98%)
At close: Oct 20, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) Non-Current Debt (2016 - 2017)

Updated

Avenue Therapeutics (ATXI) recorded Non-Current Debt of $394,000 in Q2 2017, down 64.5% from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Non-Current Debt (2016 - 2017) Analysis & Trends

At the end of FY2016, Avenue Therapeutics reported Non-Current Debt of $1.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 62.48 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 60.50 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 394,000.00
Mar 31, 2017 1.11 Mn
Dec 31, 2016 4.65 Mn
API Access

Avenue Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ATXI&period=max&api_key=YOUR_API_KEY